Search Orphan Drug Designations and Approvals
-
Generic Name: | sargramostim | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Leukine | ||||||||||||||||
Date Designated: | 05/03/1990 | ||||||||||||||||
Orphan Designation: | Treatment of neutropenia associated with bone marrow transplant, for the treatment of graft failure and delay of engraftment, and for the promotion of early engraftment. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Immunex Corporation 51 University Street Seattle, Washington 98101 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | sargramostim |
---|---|---|
Trade Name: | Leukine | |
Marketing Approval Date: | 03/05/1991 | |
Approved Labeled Indication: | ||
Exclusivity End Date: | 03/05/1998 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-